Literature DB >> 7814425

Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators.

R Donald1, D W Ballard, J Hawiger.   

Abstract

Proteolytic processing of select constituents of the nuclear factor kappa B (NF-kappa B)/inhibitor kappa B alpha (I kappa B) transcription factor system plays an important role in regulating the biological responses of monocytes to pro-inflammatory mediators. Nuclear translocation of NF-kappa B is preceded by the proteolytic degradation of I kappa B alpha, an ankyrin motif-rich inhibitor that traps NF-kappa B in the cytoplasm. In addition, formation of cytoplasmic NF-kappa B/I kappa B alpha complexes in quiescent cells requires constitutive proteolytic processing of p105, another ankyrin motif-rich inhibitory protein from which the p50 subunit of NF-kappa B is generated. We have demonstrated that, following stimulation of human monocytic cells with lipopolysaccharide or tumor necrosis factor-alpha, this critical p105 processing event is up-regulated in concert with the inactivation of I kappa B alpha. Moreover, the degradative loss of both p105 and I kappa B alpha is prevented in cells depleted of intracellular ATP. In activated monocytes, however, I kappa B alpha degradation occurs more rapidly than p105 processing to p50. Together these findings provide direct biochemical evidence that p105 and I kappa B alpha are differentially sensitive targets for inducible proteolysis via ATP-dependent degradative pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814425     DOI: 10.1074/jbc.270.1.9

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Innate immunity and inflammation: a transcriptional paradigm.

Authors:  J Hawiger
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Downregulation of the DNA-binding activity of nuclear factor-kappaB p65 subunit in Porphyromonas gingivalis fimbria-induced tolerance.

Authors:  George Hajishengallis; Robert J Genco
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

3.  An additional long-term mechanism of NF-κB regulation after cytokine treatment in a human hepatoma cell line.

Authors:  Patricia Kohlhof
Journal:  Virchows Arch       Date:  2010-09-23       Impact factor: 4.064

4.  Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.

Authors:  Jeonghee Cho; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

5.  Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide.

Authors:  M Casado; M J Díaz-Guerra; L Boscá; P Martín-Sanz
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

6.  Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.

Authors:  S Beinke; M J Robinson; M Hugunin; S C Ley
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

Authors:  D C Scherer; J A Brockman; Z Chen; T Maniatis; D W Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.

Authors:  S Beinke; J Deka; V Lang; M P Belich; P A Walker; S Howell; S J Smerdon; S J Gamblin; S C Ley
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide.

Authors:  Suraj Dhungana; B Alex Merrick; Kenneth B Tomer; Michael B Fessler
Journal:  Mol Cell Proteomics       Date:  2008-09-23       Impact factor: 5.911

10.  Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.

Authors:  Ozlem Equils; Alan Shapiro; Zeynep Madak; Chunren Liu; Daning Lu
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.